Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
Q3 2025 | 1 | -$0.33 | -$0.33 | -$0.33 |
Q4 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Precision BioSciences, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-2.83 earnings per share for the quarter, missing analysts' consensus estimates of $-0.79 by $2.04. The company had revenue of 576,000 for the quarter and had revenue of 48.73 M for the year. Precision BioSciences, Inc. has generated $-16 earnings per share over the last year ($-15.96 diluted earnings per share) and currently has a price-to-earnings ratio of 4.01. Precision BioSciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/04/2024 | Q3 2024 | -$0.79 | -$2.25 | -1.46 | $5.34 M | $576,000 |
08/01/2024 | Q2 2024 | -$0.77 | $4.70 | 5.47 | $7.70 M | $49.90 M |
05/13/2024 | Q1 2024 | -$0.45 | $1.70 | 2.15 | $17.58 M | |
03/27/2024 | Q4 2023 | -$4.06 | $7.04 M | |||
11/07/2023 | Q3 2023 | -$5.71 | -$2.10 | 3.61 | $8.99 M | $13.12 M |
08/04/2023 | Q2 2023 | -$6.91 | -$3.13 | 3.78 | $6.38 M | $19.79 M |
05/09/2023 | Q1 2023 | -$6.61 | -$6.35 | 0.26 | $8.78 M | |
03/09/2023 | Q4 2022 | -$7.21 | -$9.87 | -2.66 | $10.60 M | |
11/08/2022 | Q3 2022 | -$10.51 | -$6.76 | 3.75 | $9.86 M | $7.36 M |
08/08/2022 | Q2 2022 | -$12.91 | -$14.33 | -1.42 | $4.97 M | $3.82 M |
05/09/2022 | Q1 2022 | -$17.42 | -$14.25 | 3.17 | $3.32 M | |
03/15/2022 | Q4 2021 | -$14.41 | -$10.98 | 3.43 | $6.34 M | |
11/10/2021 | Q3 2021 | -$18.02 | -$5.67 | 12.35 | $6.02 M | $24.04 M |
08/12/2021 | Q2 2021 | -$11.41 | $11.25 | 22.66 | $13.86 M | $68.81 M |
05/13/2021 | Q1 2021 | -$14.71 | -$9.90 | 4.81 | $16.35 M | |
03/18/2021 | Q4 2020 | -$15.02 | -$13.40 | 1.62 | $8.85 M | |
11/10/2020 | Q3 2020 | -$20.42 | -$14.95 | 5.47 | $4.35 M | $7.36 M |
08/13/2020 | Q2 2020 | -$18.02 | -$18.90 | -0.88 | $5.09 M | $1.08 M |
05/15/2020 | Q1 2020 | -$15.92 | -$15.69 | 0.23 | $7.00 M | |
03/10/2020 | Q4 2019 | -$15.32 | -$12.30 | 3.02 | $6.52 M |
Precision BioSciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based off last year's report dates.
The conference call for Precision BioSciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Precision BioSciences, Inc.'s latest earnings report can be read online.
Precision BioSciences, Inc. (:DTIL) has a recorded annual revenue of $48.73 M.
Precision BioSciences, Inc. (:DTIL) has a recorded net income of $48.73 M. Precision BioSciences, Inc. has generated $-15.96 earnings per share over the last four quarters.
Precision BioSciences, Inc. (:DTIL) has a price-to-earnings ratio of 4.01 and price/earnings-to-growth ratio is -0.06.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED